$NAHD
New Asia Holdings Inc

2023 Q4 Form 10-Q Financial Statement

#000109690623002468 Filed on December 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $56.02K $26.98K $26.20K
YoY Change 70.27% 2.97% -22.46%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $56.02K $36.81K $32.77K
YoY Change 70.27% 12.33% -3.02%
Operating Profit -$36.81K -$32.77K
YoY Change 12.33% -3.02%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.500K
YoY Change
Pretax Income -$48.52K -$36.81K -$32.77K
YoY Change 47.48% 12.33% -3.02%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$48.52K -$36.81K -$32.77K
YoY Change 47.48% 12.33% -3.02%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$435.30
COMMON SHARES
Basic Shares Outstanding 75.29M shares 75.29M shares 75.29M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.880K $20.63K $15.61K
YoY Change -80.87% 32.16% -82.26%
Cash & Equivalents $1.883K $20.63K $15.61K
Short-Term Investments
Other Short-Term Assets $13.75K $2.370K $2.330K
YoY Change 5.44% 1.72% -29.39%
Inventory
Prepaid Expenses $13.75K $2.370K $2.333K
Receivables
Other Receivables
Total Short-Term Assets $15.63K $23.00K $17.94K
YoY Change -31.64% 28.18% -80.35%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.00 $200.00 $200.00
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $195.00 $195.00 $195.00
YoY Change 0.0% 0.0% -2.5%
TOTAL ASSETS
Total Short-Term Assets $15.63K $23.00K $17.94K
Total Long-Term Assets $195.00 $195.00 $195.00
Total Assets $15.83K $23.19K $18.14K
YoY Change -31.37% 27.87% -80.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $329.8K $307.6K $235.6K
YoY Change 32.56% 30.59% 48.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.359M $1.317M $1.157M
YoY Change 13.73% 13.88% 7.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.359M $1.317M $1.157M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.359M $1.317M $1.157M
YoY Change 13.73% 13.88% 7.6%
SHAREHOLDERS EQUITY
Retained Earnings -$12.83M -$12.79M -$12.61M
YoY Change 1.48% 1.36%
Common Stock $75.29K $75.29K $75.29K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.343M -$1.294M -$1.139M
YoY Change
Total Liabilities & Shareholders Equity $15.83K $23.19K $18.14K
YoY Change -31.37% 27.87% -80.18%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$48.52K -$36.81K -$32.77K
YoY Change 47.48% 12.33% -3.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$37.69K -$16.20K -$11.18K
YoY Change 24.1% 44.9% -33.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.00K 13.50K -3.250K
YoY Change -22.45% -515.38%
NET CHANGE
Cash From Operating Activities -37.69K -16.20K -11.18K
Cash From Investing Activities
Cash From Financing Activities 19.00K 13.50K -3.250K
Net Change In Cash -18.69K -2.700K -14.43K
YoY Change 218.4% -81.29% -14.56%
FREE CASH FLOW
Cash From Operating Activities -$37.69K -$16.20K -$11.18K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55410
dei Entity Registrant Name
EntityRegistrantName
NEW ASIA HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0460095
dei Entity Address Address Line1
EntityAddressAddressLine1
80 Tras Street
dei Entity Address Address Line2
EntityAddressAddressLine2
#01-03
dei Entity Address Country
EntityAddressCountry
SG
dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
079019
dei Country Region
CountryRegion
65
dei City Area Code
CityAreaCode
6820
dei Local Phone Number
LocalPhoneNumber
8885
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75288667 shares
CY2023Q3 us-gaap Cash
Cash
20626 usd
CY2022Q4 us-gaap Cash
Cash
9833 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2370 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13035 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
22996 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22868 usd
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
195 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
195 usd
CY2023Q3 us-gaap Assets
Assets
23191 usd
CY2022Q4 us-gaap Assets
Assets
23063 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
307615 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
248797 usd
CY2023Q3 fil Advance From Shareholder
AdvanceFromShareholder
1009704 usd
CY2022Q4 fil Advance From Shareholder
AdvanceFromShareholder
945704 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1317319 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1194501 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1317319 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1194501 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11416188 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11399713 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12785049 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12646034 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-556 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1294128 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23191 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23063 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
9831 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
6569 usd
us-gaap Professional Fees
ProfessionalFees
62470 usd
us-gaap Professional Fees
ProfessionalFees
39939 usd
CY2023Q3 us-gaap Selling Expense
SellingExpense
8400 usd
CY2022Q3 us-gaap Selling Expense
SellingExpense
9700 usd
us-gaap Selling Expense
SellingExpense
25200 usd
us-gaap Selling Expense
SellingExpense
26500 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18577 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16500 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51345 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54735 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
36808 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
32769 usd
us-gaap Operating Expenses
OperatingExpenses
139015 usd
us-gaap Operating Expenses
OperatingExpenses
121174 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-36808 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32769 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-139015 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-121174 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-36808 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-32769 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-139015 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-121174 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-36808 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-32769 usd
us-gaap Profit Loss
ProfitLoss
-139015 usd
us-gaap Profit Loss
ProfitLoss
-121174 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-81 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
998 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-150 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-275 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36889 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-31771 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-139165 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-121449 usd
CY2023Q3 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
CY2022Q3 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0.00
CY2023Q3 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
CY2022Q3 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
us-gaap Profit Loss
ProfitLoss
-139015 usd
us-gaap Profit Loss
ProfitLoss
-121174 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10665 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11800 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
75293 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
62617 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53057 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46757 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3248 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
64000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4752 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-150 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-275 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10793 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-42280 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9833 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57888 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20626 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15608 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1017191 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-46606 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1063808 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1262 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-41799 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1106869 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
998 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-32769 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1138640 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023Q1 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
44 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-57150 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1212069 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-113 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-45057 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1257239 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-81 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-36808 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1294128 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify">Use of Estimates</p> <p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2023; however, actual results could differ from those estimates and there may be changes to our estimates in future periods.</p>
us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
64000 usd
us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
8000 usd
CY2023Q3 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
1009704 usd
CY2022Q4 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
945704 usd
CY2023Q3 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
1009704 usd
fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd

Files In Submission

Name View Source Status
0001096906-23-002468-index-headers.html Edgar Link pending
0001096906-23-002468-index.html Edgar Link pending
0001096906-23-002468.txt Edgar Link pending
0001096906-23-002468-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nahd-20230930.htm Edgar Link pending
nahd-20230930.xsd Edgar Link pending
nahd_ex31z1.htm Edgar Link pending
nahd_ex31z2.htm Edgar Link pending
nahd_ex32z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nahd-20230930_def.xml Edgar Link unprocessable
nahd-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nahd-20230930_lab.xml Edgar Link unprocessable
nahd-20230930_pre.xml Edgar Link unprocessable
nahd-20230930_htm.xml Edgar Link completed